Improving treatment for cancer of unknown primary
Part of Cancer clinical trials.
This trial is for people with cancer of unknown primary — meaning the cancer has spread, but the original source can't be found. The study aims to better understand these cancers and find more personalized treatments by testing biopsy samples and giving tailored care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to do most daily activities on your own (ECOG score of 0, 1, or 2).
- Your doctor expects you to live at least 3 more months.
- You have cancer that has spread to other parts of your body, and doctors haven't found where it started (unknown primary).
- A biopsy (small tissue sample) from your cancer must be available for testing, or your doctor can approve an exception.
- You must be willing and able to give written permission (informed consent) and follow the study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with rare solid tumors or lymphoma to understand their cancer’s genetic changes. It collects blood and existing tissue samples (from standard care) for DNA testing and gathers health information to help improve knowledge about rare cancers.
This trial tests a special scan (18F-FAPI PET) to help find where a cancer started when the origin is unknown. The goal is to better locate the hidden tumor and guide treatment.
This trial is for people whose cancer started in an unknown place (cancer of unknown primary). It uses a special test called PaCIFiC-CUP to help classify the cancer, which may guide better treatment choices.
This trial is for people with cancer of unknown primary (CUP), meaning cancer that started in an unknown place in the body. It aims to use advanced genomic testing (looking at your tumor's DNA) on your stored tumor sample and blood to find clues about where the cancer began and possible treatment options.
This trial looks at the experiences of people with cancer of unknown primary (CUP) and their caregivers. It aims to understand what it's like to live without a clear diagnosis and how to improve support.
This study uses advanced testing (molecular profiling and imaging) to better understand cancers and help guide treatment. It is for people with certain advanced cancers who have not yet had immunotherapy or targeted therapy.
Hear when a new Cancer of Unknown Primary Site trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.